VILUCA
Dainippon Sumitomo Pharma Co., Ltd.
| Research |
OneLook
Acronym Finder
|
| Serial Number | 77068662 |
| Mark Drawing Code | 4000: Illustration: Drawing with word(s)/letter(s)/number(s) in Block form |
| Domestic Representative | Kristina M. Foudray |
| Attorney Name | Kristina M. Foudray |
| Attorney Docket Number | 8279.1147US0 |
| Law Office Assigned | M80 |
| Employee Name | CARTY, GEORGIA A |
Timeline
| 2006-12-20 | Application Filed |
| 2007-07-10 | Published for Opposition |
| 2009-03-20 | Location: INTENT TO USE SECTION |
| 2009-11-02 | Abandon |
| 2009-11-02 | Status: Dead/Abandoned |
| 2018-07-08 | Transaction Date |
Trademark Applicants & Owners
| Owner: |  DAINIPPON SUMITOMO PHARMA CO., LTD. |
| Address | 6-8, Dosho-machi 2-chome, Chuo-ku Osaka-shi, Osaka JP 541-8524 |
| Legal Entity Type | Corporation |
| Legal Entity State | JP |
Documents
Click the blue "Refresh" button to load certificates, specimines, application, and other documents.
Attorney of Record
Good, Services, and Codes
| International Codes: | 5 |
| U.S. Codes: | 006,018,044,046,051,052 |
| Type Code | Type |
|---|---|
| GS0051 | Pharmaceutical preparations, namely, anticancer preparations and anticancer antibiotics |
Trademark Filing History
| Description | Date | Event Coding |
|---|---|---|
| NEW APPLICATION ENTERED IN TRAM | 2006-12-27 | 1 NWAP I:Incoming Correspondence |
| ASSIGNED TO EXAMINER | 2007-04-13 | 2 DOCK D:Assigned to Examiner |
| NON-FINAL ACTION WRITTEN | 2007-04-13 | 3 CNRT R:Renewal |
| NON-FINAL ACTION E-MAILED | 2007-04-13 | 4 GNRT F:First Action |
| TEAS RESPONSE TO OFFICE ACTION RECEIVED | 2007-05-10 | 5 TROA I:Incoming Correspondence |
| ASSIGNED TO LIE | 2007-05-26 | 6 ALIE A:Allowance for Publication |
| CORRESPONDENCE RECEIVED IN LAW OFFICE | 2007-05-26 | 7 CRFA I:Incoming Correspondence |
| TEAS/EMAIL CORRESPONDENCE ENTERED | 2007-05-26 | 8 TEME I:Incoming Correspondence |
| APPROVED FOR PUB - PRINCIPAL REGISTER | 2007-05-28 | 9 CNSA P: |
| LAW OFFICE PUBLICATION REVIEW COMPLETED | 2007-06-01 | 10 PREV O:Outgoing Correspondence |
| NOTICE OF PUBLICATION | 2007-06-20 | 11 NPUB O:Outgoing Correspondence |
| PUBLISHED FOR OPPOSITION | 2007-07-10 | 12 PUBO A:Allowance for Publication |
| NOA MAILED - SOU REQUIRED FROM APPLICANT | 2007-10-02 | 13 NOAM O:Outgoing Correspondence |
| TEAS EXTENSION RECEIVED | 2008-02-26 | 14 EEXT I:Incoming Correspondence |
| EXTENSION 1 FILED | 2008-02-26 | 15 EXT1 S: |
| EXTENSION 1 GRANTED | 2008-02-26 | 16 EX1G S: |
| TEAS EXTENSION RECEIVED | 2008-08-26 | 17 EEXT I:Incoming Correspondence |
| EXTENSION 2 FILED | 2008-08-26 | 18 EXT2 S: |
| EXTENSION 2 GRANTED | 2008-08-26 | 19 EX2G S: |
| TEAS EXTENSION RECEIVED | 2009-03-03 | 20 EEXT I:Incoming Correspondence |
| CASE ASSIGNED TO INTENT TO USE PARALEGAL | 2009-03-20 | 21 AITU A:Allowance for Publication |
| EXTENSION 3 FILED | 2009-03-03 | 22 EXT3 S: |
| EXTENSION 3 GRANTED | 2009-03-20 | 23 EX3G S: |
| ABANDONMENT - NO USE STATEMENT FILED | 2009-11-02 | 24 ABN6 S: |
| ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED | 2009-11-02 | 25 MAB6 O:Outgoing Correspondence |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 